Position in BIIB
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$14,061,184
+$1,950,221 QoQ
Shares Held
65,080
-1.5% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#146
of 1,036 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Derivatives in BIIB
reported options exposure · as of Jun 30, 2024CallValue
$440,458
CallShares
1,900
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BANQUE PICTET & CIE SA holds $370,874,778 across 8 Drug Manufacturers - General names. BIIB ranks #7 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
409,324 | $103,002,291 | |
| 2 | LLY |
ELI LILLY & Co
|
67,095 | $80,475,762 | |
| 3 | MRK |
Merck & Co., Inc.
|
503,429 | $64,690,626 | |
| 4 | JNJ |
Johnson & Johnson
|
173,057 | $43,951,286 | |
| 5 | AZN |
Astrazeneca PLC
|
186,686 | $35,399,399 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
199,740 | $25,235,151 | |
| 7 | BIIB |
Biogen Inc.
This page
|
65,080 | $14,061,184 | |
| 8 | NVO |
Novo Nordisk A S
|
84,670 | $4,059,079 |
All Filings in BIIB
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,061,184 | 65,080 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $12,110,963 | 66,061 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $12,558,294 | 71,358 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $10,038,553 | 71,663 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $9,045,619 | 72,025 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $9,342,614 | 68,274 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $9,709,502 | 63,494 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $5,957,672 | 30,735 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $440,458 | 1,900 | Call | Sole | 2024-07-25 | |
| 2024-06-30 | $6,901,049 | 29,769 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $409,697 | 1,900 | Call | Sole | 2024-05-06 | |
| 2024-03-31 | $5,991,495 | 27,786 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $737,494 | 2,850 | Call | Sole | 2024-02-09 | |
| 2023-12-31 | $6,686,358 | 25,839 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $6,173,894 | 24,022 | Shares | Sole | 2023-11-27 | |
| 2023-06-30 | $11,216,253 | 39,376 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $12,632,015 | 45,434 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $14,952,572 | 53,996 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $12,061,725 | 45,175 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $7,800,908 | 38,251 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $12,559,973 | 59,639 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $18,493,273 | 77,081 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $6,299,923 | 22,262 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $5,167,733 | 14,924 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $4,312,626 | 15,416 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $3,950,571 | 16,134 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $4,507,958 | 15,891 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $4,325,213 | 16,166 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $6,227,307 | 19,683 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||